A Retrospective analysis of DIC score and SIC score in prediction of COVID-19 severity

Author:

Kapoor MayankORCID,Panda Prasan KumarORCID,Saini Lokesh KumarORCID,Bahurupi Yogesh ArvindORCID

Abstract

AbstractBackgroundThe novel Disseminated Intravascular Coagulation (DIC) score [platelet count, prolonged prothrombin time, D-dimer, and fibrinogen] and Sepsis Induced Coagulopathy (SIC) score [platelet count, International normalized ratio, and Sequential organ failure assessment score] are markers of coagulopathy, which, for the first time, are explored in line with the COVID-19 disease outcomes. The correlation of D-dimer with these findings is also studied.Patients and methodsA retrospective analysis of hospital-based records of 168 COVID-19 patients. Data including D-dimer, routine investigations, DIC and SIC scorings (all within three days of admission) were collected and correlated with the outcomes. The study was conducted in a tertiary care center catering to population of North India.ResultsHigher DIC score (1·59 ± 1·18 v/s 0·96 ± 1·18), SIC score (1·60 ± 0·89 v/s 0·63 ± 0·99), and D-dimer titers (1321·33 ± 1627·89 v/s 583·66 ± 777·71 ng/ml) were significantly associated with severe COVID-19 disease (P<0·05). DIC score and SIC score ≥ 1, and D-dimer ≥ 1315 ng/ml for severe disease; DIC score ≥ 1, SIC score ≥ 2, and D-dimer ≥ 600 ng/ml for Pulmonary Embolism (PE); and DIC score and SIC score ≥ 1, and D-dimer level ≥ 990 ng/ml for mortality were the respective cut-off values we found from our study.ConclusionHigher DIC scores, SIC scores, and D-dimer values are associated with severe COVID-19 disease, in-hospital mortality, and PE risk. They can serve as easily accessible early markers of severe disease and prioritize hospital admissions in the presently overburdened scenario, and may be used to develop prognostic prediction models.HighlightsDIC scores, SIC scores, and D-dimer values are hereby studied in association with COVID-19 disease severity, in-hospital mortality, and PE risk. They serve as easily accessible early markers of severe disease and prioritize hospital admissions in the presently overburdened scenario, and may be used to develop prognostic prediction models.

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3